156 related articles for article (PubMed ID: 8690997)
1. [Malignancy associated with hypercalcemia].
Eto S
Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):371-6. PubMed ID: 8690997
[No Abstract] [Full Text] [Related]
2. [Physiopathology and therapy of hypercalcemia associated with malignancies].
Ikeda K
Nihon Naika Gakkai Zasshi; 1999 Jul; 88(7):1212-7. PubMed ID: 10465966
[No Abstract] [Full Text] [Related]
3. [Treatment of malignancy-associated hypercalcemia].
Endo I; Inoue D
Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
[TBL] [Abstract][Full Text] [Related]
4. [Hypercalcemia in malignancy].
Eto S
Rinsho Byori; 1994 Sep; 42(9):943-51. PubMed ID: 7967119
[TBL] [Abstract][Full Text] [Related]
5. [Pathophysiology and treatment of malignancy-associated hypercalcemia].
Miyauchi A
Nihon Rinsho; 2006 Jun; Suppl 2():161-4. PubMed ID: 16817374
[No Abstract] [Full Text] [Related]
6. [Treatment of malignancy associated hypercalcemia].
Tai N; Inoue D
Clin Calcium; 2014 Aug; 24(8):1223-8. PubMed ID: 25065875
[TBL] [Abstract][Full Text] [Related]
7. [Malignancy-associated hypercalcemia].
Sato K
Nihon Naika Gakkai Zasshi; 1995 May; 84(5):808-12. PubMed ID: 7616098
[No Abstract] [Full Text] [Related]
8. Hypercalcaemia due to malignancy. Role of the kidney and treatment.
Sleeboom HP; Bijvoet OL
Contrib Nephrol; 1982; 33():178-96. PubMed ID: 6214375
[No Abstract] [Full Text] [Related]
9. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
[TBL] [Abstract][Full Text] [Related]
10. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
11. [Medical treatment of malignant hypercalcemia].
Eto S; Nakano Y; Okada Y
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
[TBL] [Abstract][Full Text] [Related]
12. [Progress in therapy and diagnosis: Hypercalcemia due to parathyroid hormone-related protein producing neoplasms].
Tanaka Y; Okada Y
Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):669-74. PubMed ID: 17506302
[No Abstract] [Full Text] [Related]
13. Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases.
de Vernejoul MC
Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):119S-123S. PubMed ID: 9273953
[No Abstract] [Full Text] [Related]
14. [Physiopathology and therapy of hypercalcemia crisis].
Sato K
Nihon Naika Gakkai Zasshi; 1999 Jul; 88(7):1228-32. PubMed ID: 10465969
[No Abstract] [Full Text] [Related]
15. [Hypercalcemia in neoplastic and granulomatous diseases: pathogenesis and treatment options].
Igaz P; Tulassay Z
Orv Hetil; 2005 Jul; 146(31):1631-4. PubMed ID: 16158612
[TBL] [Abstract][Full Text] [Related]
16. [Hypercalcemia as an emergency].
Rosenmund A
Schweiz Med Wochenschr; 1993 Apr; 123(15):735-8. PubMed ID: 8488377
[TBL] [Abstract][Full Text] [Related]
17. Hypercalcemia of malignancy: diagnosis and therapy.
Fetchick DA; Mundy GR
Compr Ther; 1986 Aug; 12(8):27-32. PubMed ID: 2943551
[TBL] [Abstract][Full Text] [Related]
18. [Hypercalcemia in malignancy].
Eto S
Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1534-9. PubMed ID: 1837045
[No Abstract] [Full Text] [Related]
19. Treatment of hypercalcaemia of malignancy.
Heath DA
Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):139-45. PubMed ID: 2143893
[TBL] [Abstract][Full Text] [Related]
20. Acute management of cancer-related hypercalcemia.
Chisholm MA; Mulloy AL; Taylor AT
Ann Pharmacother; 1996 May; 30(5):507-13. PubMed ID: 8740333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
